0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Using early on-treatment circulating tumor DNA measurements as response assessment in metastatic castration resistant prostate cancer

      editorial

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Author and article information

          Journal
          Oncotarget
          Oncotarget
          Impact Journals LLC
          Oncotarget
          Impact Journals LLC
          1949-2553
          2024
          02 July 2024
          : 15
          : 421-423
          Author notes
          Correspondence to: Niven Mehra, Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands email niven.mehra@ 123456radboudumc.nl
          Article
          28599
          10.18632/oncotarget.28599
          11218791
          38953903
          8523cfb9-6430-463e-8228-1e71db954a09
          Copyright: © 2024 Tolmeijer et al.

          This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

          History
          : 01 June 2024
          Categories
          Editorial

          Oncology & Radiotherapy
          ctdna,prostate cancer,liquid biopsy,biomarker,androgen receptor pathway inhibitors

          Comments

          Comment on this article